Small‐volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions
Open Access
- 6 June 2002
- journal article
- review article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 46 (6) , 625-638
- https://doi.org/10.1034/j.1399-6576.2002.460601.x
Abstract
Background: The concept of small‐volume resuscitatioin (SVR) using hypertonic solutions encompasses the rapid infusion of a small dose (4 ml per kg body weight, i.e. approximately 250 ml in an adult patient) of 7.2–7.5% NaCl/colloid solution. Originally, SVR was aimed for initial therapy of severe hypovolemia and shock associated with trauma.Methods: The present review focusses on the findings concerning the working mechanisms responsible for the rapid onset of the circulatory effect, the impact of the colloid component on microcirculatory resuscitation, and describes the indications for its application in the preclinical scenario as well as perioperatively and in intensive care medicine.Results: With respect to the actual data base of clinical trials SVR seems to be superior to conventional volume therapy with regard to faster normalization of microvascular perfusion during shock phases and early resumption of organ function. Particularly patients with head trauma in association with systemic hypotension appear to benefit. Besides, potential indications for this concept include cardiac and cardiovascular surgery (attenuation of reperfusion injury during declamping phase) and burn injury. The review also describes disadvantaages and potential adverse effects of SVR:Conclusion: Small‐volume resuscitation by means of hypertonic NaCl/colloid solutions stands for one of the most innovative concepts for primary resuscitation from trauma and shock established in the past decade. Today the spectrum of potential indications envolves not only prehospital trauma care, but also perioperative and intensive care therapy.Keywords
This publication has 66 references indexed in Scilit:
- HEMODYNAMIC EFFECTS OF HYPERTONIC HYDROXYETHYL STARCH 6% SOLUTION AND ISOTONIC HYDROXYETHYL STARCH 6% SOLUTION AFTER DECLAMPING DURING ABDOMINAL AORTIC ANEURYSM REPAIRShock, 2000
- Hyperosmotic saline solutions in clinical patient careCurrent Opinion in Critical Care, 1999
- Hypertonic saline dextran: efficacy and regulatory approvalActa Anaesthesiologica Scandinavica, 1998
- PROGNOSTIC FACTORS TO PREDICT OUTCOME FOLLOWING THE ADMINISTRATION OF HYPERTONIC/HYPERONCOTIC SOLUTION IN HYPOVOLEMIC PATIENTSShock, 1997
- EFFECTS OF HYPERTONIC-HYPERONCOTIC INFUSION ON THE HUMAN ATRIAL NATRIURETIC FACTOR IN A STANDARDIZED CLINICAL TRIALShock, 1995
- Small-volume resuscitationCurrent Opinion In Anesthesiology, 1993
- Use of hypertonic saline/dextran versus lactated ringer's solution as a resuscitation fluid after uncontrolled aortic hemorrhage in anesthetized swineAnnals of Emergency Medicine, 1992
- Acute and subacute toxicity of 7.5% hypertonic saline/6% dextran-70 (hsd) in dogs 1. serum immunoglobulin and complement responsesJournal of Applied Toxicology, 1992
- Dextran metabolism following infusion of 7.5% NaCl/6% dextran-70 to euvolemic and hemorrhaged rabbitsDrug Development Research, 1992
- Dextran hypersensitivityImmunology Today, 1982